Zobrazeno 1 - 4
of 4
pro vyhledávání: '"L Peries Reverter"'
Autor:
C Rubín De Célix, J Martín de Carpi, G Pujol, L Palomino, M Velasco, R Martín-Masot, V M Navas-López, E Ricart, M J Casanova, A Rodríguez Martínez, E Leo, A Alcaraz, M Mañosa, V Hernández, R Fernández, C Sánchez, L Menchén, F Mesonero, M Barreiro-De Acosta, N Martinon, C Tejido Sandoval, A Rendo Vázquez, P Corsino, R Vicente, A Hernández-Camba, J R Alberto Alonso, I Alonso-Abreu, A M Castro Millán, L Peries Reverter, B Castro, E Fernández-Salgado, M M Busto Cuiñas, J M Benítez, L Madero, F Clemente, S Riestra, S Jiménez-Treviño, M Boscá, M Chaparro, J P Gisbert
Publikováno v:
Journal of Crohn's and Colitis. 17:i37-i39
Background It has been suggested that the transition of patients from paediatric to adult care units may be key in the outcomes of inflammatory bowel disease (IBD). However, the impact of transition in real clinical practice has been barely studied.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e5b5cdf6fe59db8a2da918c9b10143c
https://doi.org/10.1093/ecco-jcc/jjac190.0027
https://doi.org/10.1093/ecco-jcc/jjac190.0027
Autor:
L. Peries Reverter, C. Diez Vallejo, G. Alvarez, A. Castro Guardiola, M. Rexach Fumaña, A. Uribe Luna, L. Viñas Sague, A. Perez Jaen
Publikováno v:
Annals of the Rheumatic Diseases. 80:856.3-857
Background:Biological therapies have marked a difference in the treatment of many autoimmune conditions. As all treatments, they have their side effects although little evidence of long-term effects has been reported.Objectives:Analyze retrospectivel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87ff65ac018287229fb55a78f9a61ff6
https://doi.org/10.1136/annrheumdis-2021-eular.3130
https://doi.org/10.1136/annrheumdis-2021-eular.3130
Autor:
Ainara Elorza, C De Galan, M. De Vos, L Vandermeulen, A Jauregui Amezaga, R Ferreiro-Iglesias, F Mesonero Gismero, L Peries Reverter, Jeroen Geldof, T Lobaton, Harald Peeters, Tom Holvoet, Y Zabana, Paola Torres, M Truyens, G. Varkas
Publikováno v:
Journal of Crohn's and Colitis. 15:S302-S302
Background Extra-intestinal manifestations (EIM) are frequently reported in inflammatory bowel diseases (IBD). Although the efficacy of TNF inhibitors is well documented, data regarding the effect of vedolizumab (VDZ) and ustekinumab (UST) are limite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2e34935f52addf0ed8236a9ffee9d00
https://doi.org/10.1093/ecco-jcc/jjab076.391
https://doi.org/10.1093/ecco-jcc/jjab076.391
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.